What makes a good RP?
Recommendation
9 September 2025
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
Register now for ECA's GMP Newsletter
In a recent blog, the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) discusses possibilities (and expectations) for an effective appointment and training for the Responsible Person (RP) named on the Wholesale Distribution Authorisation (WDA).
The MHRA sees a number of "key areas" an RP and its employer should consider and which MHRA "will address in turn":
- Knowledge of GDP and the relevant regulations - this is the text book stuff.
- Industry experience - relevant GDP experience.
- Familiarity with the GDP operations of the Licence Holder - particularly challenging in a large organisation.
- Induction/primary training - role familiarity.
- Role definition and place within the organisation - sufficient seniority and influence.
- Delegation and training others - The RP is responsible for all GDP activities, even those delegated.
- Training records - RP, Licence Holder and staff.
- Continuing development for the RP - the supply chain continually presents new challenges.
Source: Quelle: MHRA Inspectorate Blog "The Responsible Person named on the WDA -Part 2: Effective Appointment and Training".
Related GMP News
15.07.2025New Swissmedic Technical Interpretation on Returns of Medicinal Products
15.07.2025Two new GDP Non-Compliance Reports from Austria and Ireland published in the EudraGMDP database
15.07.2025Reminder: Participate in the GDP Implementation Survey until 31 July 2025
15.07.2025PDA Publishes Results of Transportation Validation Benchmarking Survey
10.06.2025Stimuli Article Proposes Revision of USP Definition of Controlled Room Temperature (CRT)
10.06.2025New MHRA Blog Post: Supplying Medicines to Ships, Aircraft and Oil Platforms